Moody Aldrich Partners LLC decreased its position in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 9.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 124,984 shares of the company’s stock after selling 12,528 shares during the period. Moody Aldrich Partners LLC owned about 0.07% […]
Moody Aldrich Partners LLC cut its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 9.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 124,984 shares of the company’s stock after selling 12,528 shares during the period. Moody Aldrich Partners LLC’s holdings in BridgeBio Pharma were worth $5,046,000 as of […]
China Universal Asset Management Co Ltd Acquires 15,949 Shares of BridgeBio Pharma, Inc (NASDAQ:BBIO) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $29.76, but opened at $30.49. BridgeBio Pharma shares last traded at $30.08, with a volume of 180,372 shares traded. Wall Street Analyst Weigh In Several brokerages have issued reports on BBIO. […]
Raymond James initiated coverage on shares of BridgeBio Pharma (NASDAQ:BBIO – Free Report) in a research note issued to investors on Thursday, StockNewsAPI reports. The firm issued an outperform rating and a $45.00 price target on the stock. Other analysts have also recently issued reports about the stock. Citigroup lifted their price objective on shares […]